CN105699370B - Amniotic fluid detects director composition, its preparation and corresponding amniotic fluid detection protection pad - Google Patents

Amniotic fluid detects director composition, its preparation and corresponding amniotic fluid detection protection pad Download PDF

Info

Publication number
CN105699370B
CN105699370B CN201610036848.9A CN201610036848A CN105699370B CN 105699370 B CN105699370 B CN 105699370B CN 201610036848 A CN201610036848 A CN 201610036848A CN 105699370 B CN105699370 B CN 105699370B
Authority
CN
China
Prior art keywords
amniotic fluid
protection pad
fluid detection
director composition
detection protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201610036848.9A
Other languages
Chinese (zh)
Other versions
CN105699370A (en
Inventor
高阳
甘少磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangxi Huaqing Boen Biological Technology Co Ltd
Original Assignee
Jiangxi Huaqing Boen Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangxi Huaqing Boen Biological Technology Co Ltd filed Critical Jiangxi Huaqing Boen Biological Technology Co Ltd
Priority to CN201610036848.9A priority Critical patent/CN105699370B/en
Publication of CN105699370A publication Critical patent/CN105699370A/en
Application granted granted Critical
Publication of CN105699370B publication Critical patent/CN105699370B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N2021/775Indicator and selective membrane

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

The invention discloses amniotic fluid to detect director composition, it is prepared and corresponding amniotic fluid detection protection pad, the amniotic fluid detection director composition includes with water, ethyl alcohol, acetone, N, one or both of N dimethylformamides are solvent, with pulullan polysaccharide, sodium alginate, ethyl cellulose, one or more in sodium carboxymethylcellulose are film forming agent, using dioctyl phthalate as plasticiser, with ethylene glycol, glycerine, ethylene glycol ethyl ether is wetting agent, with bromthymol blue sodium salt, xylene bromide phenol is blue, sodium alizarine sulphonate, bromocresol purple is indicator, amniotic fluid detection indicator is prepared at normal temperatures, then it is coated onto on medical sanitary pad, drying is prepared into amniotic fluid detection protection pad.The present invention is easy to use, is not easy to decolourize, it is easier to be received by patient, and can distinguish amniotic fluid and urine, entire technological operation is simple, it is easy to accomplish large-scale production.

Description

Amniotic fluid detects director composition, its preparation and corresponding amniotic fluid detection protection pad
Technical field
The invention belongs to medical dressing field, it is related to a kind of amniotic fluid detection director composition, preparation method and corresponding Amniotic fluid detection protection pad.
Background technology
Rupture of membranes (ROM) may at any time occur during the pregnancy period, be ruptured under normal circumstances in term birth, but such as Fruit occurs surprisingly suspender for pregnant woman will being given to carry out various pains in antenatal too early rupture.Fetal membrane is ruptured before term birth, referred to as tire Film is early broken or PROM;The incidence of premature rupture of fetal membranes PROM is about 10% after 37 pregnant weeks under normal conditions, the generation of ROM before 37 pregnant weeks Rate is 2-3.5%, referred to as PPROM.PROM is to cause an antenatal and postpartum complication principal element, is to lead to premature labor and must The main reason for neonatal complications of NICU treatments must be moved in.Due to medical worker have to extend pregnant week with it is in utero and pregnant Woman infection risk and fetus lung development problem between seek balance, difficulty not only of high cost to the management of PROM and PPROM patients but also Greatly.Thus, correct, timely diagnosis is very crucial.
At this stage for the diagnosis of PROM, only often it is not enough to confirm the state of fetal membrane with medical history and physical examination.At present Detection method is broadly divided into:1. supersonic testing method;2.pH test paper detection methods;3. insulin-like growth factor binding protein detects Method.But amniotic fluid leakage rate is smaller, and the amniotic fluid assessed may be can't see in vagina, amniotic fluid is also possible to viscous with urine, uterine neck The pollutions such as liquid, vaginal fluid, blood or meconium, to cause the error of detection.Patent CN201220572286.7 is disclosed PH test paper is positioned in protection pad by a kind of amniotic fluid detection protection pad, and the pH by detecting vagina omission timber, which changes to detect amniotic fluid, is No leakage, but when containing urine in vagina omission timber, pH test paper may still change colour, therefore amniotic fluid and urine cannot be distinguished, To easily cause erroneous judgement, and pH test paper encounters easy decoloration when urine or amniotic fluid, to pollute contacted skin and clothing Object.Patent CN201520302623.4 is disclosed a kind of amniotic fluid detection health-care protection pad and is passed through using anthocyanidin as indicator The pH of detection vagina omission timber changes to judge whether amniotic fluid leaks, but amniotic fluid and urine still cannot be distinguished in the method, and And color change unobvious, it be easy to cause erroneous judgement.Patent CN03824113.7 discloses amniotic fluid in a kind of detection vaginal fluid Device and method, antibody is detected by PAMG-1 and detects a small amount of amniotic fluid in vagina, detection method sensitivity is higher, still Detection swab, which generally requires, gos deep into vagina 5-7cm, is easy to carry out sense of discomfort to suspender for pregnant woman, and there are certain risks.
As it can be seen that in this field there are still for it is easy to use, be not easy to decolourize, be easy to be received, compared with the Supreme People's Procuratorate by patient It surveys sensitivity, amniotic fluid can be distinguished and the demand of the amniotic fluid detection product of urine.
Invention content
Present invention aims at provide it is a kind of it is easy to use, be not easy to decolourize, significantly and amniotic fluid and urine can be easily distinguished The amniotic fluid of liquid detects product, specifically includes amniotic fluid detection director composition and is prepared by amniotic fluid detection director composition Amniotic fluid detection protection pad.
To achieve the above object, the present invention uses following technical scheme:Amniotic fluid detects director composition comprising: 80%-99%(w/w)The solvent selected from water, ethyl alcohol, acetone, one or both of N,N-dimethylformamide;0.1%-5% (w/w)The film forming selected from pulullan polysaccharide, ethyl cellulose, sodium alginate, one or both of sodium carboxymethylcellulose Agent;0.05%-3%(w/w)The plasticiser selected from dioctyl phthalate;0.5%-10%(w/w)Selected from ethylene glycol, the third three The wetting agent of one or more of alcohol, ethylene glycol ethyl ether;And 0.01%-1%(w/w)Selected from bromthymol blue sodium salt, The indicator of two or more in xylene bromide phenol indigo plant, sodium alizarine sulphonate, bromocresol purple.
The invention further relates to the preparation methods that above-mentioned amniotic fluid detects director composition comprising by the amniotic fluid indicator group The each component for closing object is uniformly dissolved to obtain amniotic fluid detection director composition at normal temperatures.
The invention further relates to the amniotic fluid detection protection pads obtained by amniotic fluid detection director composition, pass through such as lower section Method obtains:
(1) preparation of amniotic fluid detection director composition:
The each component that amniotic fluid in claim 1 is detected to director composition is uniformly dissolved to obtain amniotic fluid inspection at normal temperatures Survey director composition;
(2) preparation of amniotic fluid detection protection pad:
The amniotic fluid being prepared in step (1) detection director composition is uniformly applied on medical sanitary pad, so After dry 3-30h, obtain amniotic fluid detection protection pad.
Protection pad drying temperature is in the present invention:20-50℃.
Applying amount of the amniotic fluid detection indicator on Medical protective pad is in the present invention:0.01-0.5ml/cm2
The advantage of the invention is that:
The amniotic fluid detection protection pad of preparation is easy to use, is not easy to decolourize, it is easier to be received by patient, and can distinguish amniotic fluid And urine, entire technological operation are simple, it is easy to accomplish large-scale production.
Specific implementation mode:
Embodiment 1
1.0g pulullan polysaccharides are weighed, are dissolved in 67g water, after stirring and dissolving is uniform, sequentially add 0.73g neighbours Dioctyl phthalate, 0.93g ethylene glycol are uniformly mixing to obtain solution A under room temperature (25 DEG C).
16mg bromthymol blues sodium salt and 10mg sodium alizarine sulphonates are weighed, is placed in 1.5g water and is uniformly dissolved to obtain solution B, Then solution A and B solution are mixed evenly to obtain amniotic fluid detection indicator under room temperature (25 DEG C).Take above-mentioned indicator molten Liquid is according to 0.1ml/cm2Dosage be equably applied on medical sanitary pad, be then made after 50 DEG C of dry 10h amniotic fluid detection Protection pad.
Embodiment 2
1.0g ethyl celluloses are weighed, are dissolved in 40g ethyl alcohol, after stirring and dissolving is uniform, sequentially add 0.52g Dioctyl phthalate, 1.02g glycerine, are uniformly mixing to obtain solution A.
12mg xylene bromide phenol indigo plants and 15mg bromocresol purples are weighed, is placed in 2g water and is uniformly dissolved to obtain solution B, then will Solution A is mixed evenly to obtain amniotic fluid detection indicator with B solution.Take above-mentioned indicator solution according to 0.07ml/cm2Use Amount is equably applied on medical sanitary pad, and amniotic fluid detection protection pad then is made after 45 DEG C of dry 15h.
Embodiment 3
1.0g sodium alginates are weighed, are dissolved in 70g water, after stirring and dissolving is uniform, sequentially add 0.63g neighbour's benzene Diformazan dioctyl phthalate, 0.75g ethylene glycol ethyl ethers, are uniformly mixing to obtain solution A.
7mg bromthymol blues sodium salt, 5mg xylene bromides phenol indigo plant, 10mg bromocresol purples are weighed, is placed in 2.5g water and dissolves It is even to obtain solution B, then solution A and B solution are mixed evenly to obtain amniotic fluid detection indicator.Take above-mentioned indicator solution According to 0.1ml/cm2Dosage be equably applied on medical sanitary pad, be then made after 35 DEG C of dry 20h amniotic fluid detection shield Pad.
Embodiment 4
1.0g sodium carboxymethylcelluloses are weighed, are dissolved in 80g water, after stirring and dissolving is uniform, are sequentially added 0.94g dioctyl phthalates, 1.21g ethylene glycol, are uniformly mixing to obtain solution A.
It is blue to weigh blue 15mg xylene bromides phenol, 5mg bromocresol purples and 13mg xylene bromides phenol, is placed in 1.5g water and dissolves It is even to obtain solution B, then solution A and B solution are mixed evenly to obtain amniotic fluid detection indicator.Take above-mentioned indicator solution According to 0.2ml/cm2Dosage be equably applied on medical sanitary pad, be then made after 30 DEG C of dry 30h amniotic fluid detection shield Pad.
Comparative example 1
16mg bromthymol blues sodium salt and 10mg sodium alizarine sulphonates are weighed, is placed in 1.5g water and is uniformly dissolved to obtain solution, Take above-mentioned indicator solution according to 0.1ml/cm2Dosage be equably applied on medical sanitary pad, then 50 DEG C of dry 10h After amniotic fluid detection protection pad is made.
Comparative example 2
Commercially available pH test paper(Range is 1-14).
Comparative example 3
1 detection kit of commercially available insulin-like growth factor binding protein-.
Product decoloration contrast test
The product of Example 1-4 and comparative example 1-3 are cut into strip of the same area(1cm×4cm),
Then it is immersed in respectively and is filled in the buffer solution that 100ml pH are 5.0, pull sample after separated in time out Then product stir the water in beaker with glass bar, the color change of water in the cup is burnt in observation after making color diffusion uniformly, and records number According to:
Compared with contrast groups 1-2, the color fastness of sample prepared by embodiment 1-4 is higher, only has after 30 minutes slight Decoloration, and with the growth of time, bleaching level does not increase, and product prepared by contrast groups 1-2 goes out rapidly into the water It now decolourizes phenomenon, and decoloration gradually increases in the short time, color throw is than more serious, and product is not due to having color in comparative example 3 Plain ingredient, therefore without decoloration phenomenon.
Product comfort level compares
The sample of Example 1-4 and comparative example 1-3 obtain the comfortable degrees of data of product according to the analysis of application method:
Compared with contrast groups 2-3, the amniotic fluid detection protection pad and the conventional protection pad that are prepared with comparative example 1 using embodiment 1-4 are made Consistent with method, comfort level is higher, but amniotic fluid detection protection pad prepared by comparative example 1 has a slight decoloration, and comparative example 2 In commercially available pH test paper operability it is poor, it is not only unhygienic but also inconvenient.3 product of comparative example is invasive relatively strong, is easy to make to pregnant woman At the sense of urgency, comfort is poor.
Amniotic fluid and urine detection experiment
It is first used wetted with urine by the product of Example 1-4 and comparative example 1-3, observes color change situation, then will It is respectively placed in dry place and dries 30min, then observes color change situation, and records data.
Test result:
The product of Example 1-4 and comparative example 1-2 first soak it with amniotic fluid, observe color change situation, then will It is respectively placed in dry place and dries 30min, then observes color change situation, and records data.
Test result:
It compared with contrast groups 2, meets amniotic fluid using amniotic fluid detection protection pad prepared by embodiment 1-4 and becomes blue-green, and meet urine Non-discolouring or change blue-green, after meeting urine change blue-green, bluish-green decoloration becomes faint yellow after placing 30 minutes, and meets amniotic fluid After becoming blue-green, become dark blue-green after placing 30 minutes, so amniotic fluid detection protection pad prepared by embodiment 1-4 completely can be with area Amniotic fluid and urine are separated, and the amniotic fluid in comparative example 1 monitors protection pad and meets urine as commercially available pH Test papers in comparative example 2 Both all become light blue with amniotic fluid, so cannot be distinguished.3 product of comparative example chance urine is non-discolouring, meets amniotic fluid and becomes red, can be with area Divide amniotic fluid and urine, but is detected since swab is goed deep into vagina 5-7cm by its needs, so be easy to carry out sense of discomfort to suspender for pregnant woman, Inconvenient to use, comfort is poor.
In conclusion the amniotic fluid detection protection pad that is produced of method of the present invention has easy to use, it is not easy to decolourize, it is easier to Received by patient, and amniotic fluid and urine can be distinguished, the product being significantly better than in comparative example 1-3.
The preferred embodiment of the present invention has been described above in detail, still, during present invention is not limited to the embodiments described above Detail can carry out a variety of simple variants to technical scheme of the present invention within the scope of the technical concept of the present invention, this A little simple variants all belong to the scope of protection of the present invention.
It is further to note that specific technical features described in the above specific embodiments, in not lance In the case of shield, can be combined by any suitable means, in order to avoid unnecessary repetition, the present invention to it is various can The combination of energy no longer separately illustrates.
In addition, various embodiments of the present invention can be combined randomly, as long as it is without prejudice to originally The thought of invention, it should also be regarded as the disclosure of the present invention..

Claims (5)

1. a kind of amniotic fluid detects director composition comprising:80%-99%'s (w/w) is selected from water, ethyl alcohol, acetone, N, N- bis- The solvent of one or both of methylformamide;0.1%-5%'s (w/w) is selected from pulullan polysaccharide, ethyl cellulose, alginic acid The film forming agent of one or both of sodium, sodium carboxymethylcellulose;0.05%-3% (w/w) selected from dioctyl phthalate Plasticiser;The wetting agent selected from one or more of ethylene glycol, glycerine, ethylene glycol ethyl ether of 0.5%-10% (w/w); With the indicator chosen from the followings of 0.01%-1% (w/w):The combination of bromthymol blue sodium salt and sodium alizarine sulphonate, xylene bromide phenol Blue and bromocresol purple combination or the combination of bromthymol blue sodium salt, xylene bromide phenol indigo plant and bromocresol purple.
2. the preparation method of the amniotic fluid director composition of claim 1 comprising by each group of the amniotic fluid director composition Divide and is uniformly dissolved to obtain amniotic fluid detection director composition at normal temperatures.
3. a kind of amniotic fluid detection protection pad, obtains by the following method:
(1) preparation of amniotic fluid detection director composition:
The each component that amniotic fluid in claim 1 is detected to director composition is uniformly dissolved to obtain amniotic fluid and detect to refer at normal temperatures Show agent composition;
(2) preparation of amniotic fluid detection protection pad:
The amniotic fluid being prepared in step (1) detection director composition is uniformly applied on medical sanitary pad, is then dried Dry 3-30h, obtains amniotic fluid detection protection pad.
4. amniotic fluid detection protection pad according to claim 3, it is characterised in that drying temperature is in step (2):20-50℃.
5. amniotic fluid detection protection pad according to claim 3, it is characterised in that amniotic fluid detection director composition is being cured in step (2) It is with the applying amount on protection pad:0.01-0.5ml/cm2
CN201610036848.9A 2016-01-20 2016-01-20 Amniotic fluid detects director composition, its preparation and corresponding amniotic fluid detection protection pad Expired - Fee Related CN105699370B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610036848.9A CN105699370B (en) 2016-01-20 2016-01-20 Amniotic fluid detects director composition, its preparation and corresponding amniotic fluid detection protection pad

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610036848.9A CN105699370B (en) 2016-01-20 2016-01-20 Amniotic fluid detects director composition, its preparation and corresponding amniotic fluid detection protection pad

Publications (2)

Publication Number Publication Date
CN105699370A CN105699370A (en) 2016-06-22
CN105699370B true CN105699370B (en) 2018-09-18

Family

ID=56226750

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610036848.9A Expired - Fee Related CN105699370B (en) 2016-01-20 2016-01-20 Amniotic fluid detects director composition, its preparation and corresponding amniotic fluid detection protection pad

Country Status (1)

Country Link
CN (1) CN105699370B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107576653B (en) * 2017-06-24 2023-03-17 中瀚利加(北京)科技有限公司 Composition for identifying amniotic fluid of pregnant woman
CN109900690B (en) * 2019-04-04 2021-12-14 青岛大学 Preparation method and application of sol for green rapid detection of sulfur ions
CN109900692B (en) * 2019-04-04 2021-11-26 青岛大学 Preparation method of gel for green and efficient detection of mercury ions and application of gel
CN109900691B (en) * 2019-04-04 2021-11-19 青岛大学 Test paper for rapidly detecting mercury ions, preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101309929A (en) * 2005-09-15 2008-11-19 创源生物科技(武汉)有限公司 A marker for prolonged rupture of membranes
CN102297963A (en) * 2011-05-30 2011-12-28 吉权 Premature rupture of membrane colloidal gold test paper reaction buffer, and preparation method thereof
CN103999782A (en) * 2014-06-05 2014-08-27 江苏中恒宠物用品股份有限公司 Production technology for pet urinal pad having disease detection function
CN204636718U (en) * 2015-05-12 2015-09-16 辛琰琰 Amniotic fluid detects health-care protection pad

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010025140A1 (en) * 1998-07-22 2001-09-27 Torok Brian A. System for identifying premature rupture of membrane during pregnancy
US6627394B2 (en) * 2001-07-19 2003-09-30 Common Sense Ltd. Diagnostic pad
DK1535068T3 (en) * 2002-08-13 2010-08-09 N Dia Inc Devices and methods for the detection of amniotic fluid in vaginal secretions
US7935538B2 (en) * 2006-12-15 2011-05-03 Kimberly-Clark Worldwide, Inc. Indicator immobilization on assay devices

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101309929A (en) * 2005-09-15 2008-11-19 创源生物科技(武汉)有限公司 A marker for prolonged rupture of membranes
CN102297963A (en) * 2011-05-30 2011-12-28 吉权 Premature rupture of membrane colloidal gold test paper reaction buffer, and preparation method thereof
CN103999782A (en) * 2014-06-05 2014-08-27 江苏中恒宠物用品股份有限公司 Production technology for pet urinal pad having disease detection function
CN204636718U (en) * 2015-05-12 2015-09-16 辛琰琰 Amniotic fluid detects health-care protection pad

Also Published As

Publication number Publication date
CN105699370A (en) 2016-06-22

Similar Documents

Publication Publication Date Title
CN105699370B (en) Amniotic fluid detects director composition, its preparation and corresponding amniotic fluid detection protection pad
AU2003278582B2 (en) Secretion-testing article
US6627394B2 (en) Diagnostic pad
CN107238524B (en) improved special dyeing diagnostic solution
WO2013008239A1 (en) Noninvasive detection of meconium in amniotic fluid
CA2670403A1 (en) Diagnostic composition and article for monitoring intravaginal infections
US20210041424A1 (en) Formulations comprising mercury-containing reagents for detecting disease
CN104585162B (en) A kind of nontoxic liquid based cell preservative fluid of novel environment friendly
CN102321730A (en) Joint vaginitis detection kit
US11135338B2 (en) Diagnostic composition for identifying amniotic fluid
Bourgeois The identification of fetal squamas and the diagnosis of ruptured membranes by vaginal smear
JPS58501596A (en) Fertility indication system
CN202975020U (en) Detection apparatus capable of rapidly detecting human chorionic gonadotrophin in quantitative manner
CN103529206B (en) A kind of interstitialcellstimulating hormone (ICSH) and bacterial vaginitis joint inspection kit
CN106226295A (en) A kind of urine sulfhydryl compound detectable and preparation method
CN107576653B (en) Composition for identifying amniotic fluid of pregnant woman
CN201876456U (en) Joint inspection kit for premature birth of pregnant woman and premature rupture of membrane
CN105758971B (en) The method of quality control of Policresulen bolt
CN108645850A (en) A kind of swab and its preparation method and application
RU2637649C2 (en) Method and indicating reagent for vaginal fluid ph-metry
WO2014131359A1 (en) Method for preparing immunochromatographic test strip that detects premature rupture of fetal membrane
Fahmy et al. Fetal Monitoring–Current Concepts
Hooper et al. Vaginal pH Test (pH Hydrion TM Paper 4.5-7.5)
IL168193A (en) Secretion-testing article

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180918

Termination date: 20210120